CN

Because of the popularity of cancer immunotherapy and monoclonal antibody drugs, biopharmaceuticals have entered the fast lane of technology iteration. While pursuing the upgrading of production capacity, biopharmaceuticals have made great efforts to improve the biological activity and process optimization of products. In addition, they have put forward higher requirements for the professionalization of various links in the industrial chain.
With a comprehensive cell, molecular and immune product line, Genetime Excell Bio co.ltd can provide high-quality imported fetal bovine serum, serum-free medium and other core reagents for cell culture and related products for the biopharmaceutical industry, as well as qPCR Mix, ELISA detection kit and other transcription and translation detection and identification tools.


  • Retro-Concentin Virus Precipitation Solution(5X)(EMB100A-1)

    sketch Retroviral gene transfer is a technique for efficiently introducing stable, heritable gene...
    apply
    specs100mL
  • Taq-Antibody(MB022-0011、0012)

    sketch Taq Antibody是在PCR熱啟動(dòng)體系中用于抗Taq DNA聚合酶的抗體,通過與Taq DNA聚合酶結(jié)合抑制酶活性...
    apply
    specs10 ml,50 ml
  • T4 Polynucleotide Kinase(MB000-5401)

    sketch 本酶能夠催化將ATP上的?磷酸基團(tuán)轉(zhuǎn)移到雙鏈或單鏈DNA的5'末端。
    applyDNA或RNA的5'末端放射性標(biāo)記,以制備探針; 寡聚核苷酸的5'末端進(jìn)行磷酸化,以方便進(jìn)行連接反應(yīng); 除去寡聚核苷酸的3'末端的磷酸基團(tuán)。
    specs250U,500U,2,500U,10,000U
  • T4 DNA Polymerase(MB000-1571)

    sketch 在模板和引物存在的條件下,T4 DNA 聚合酶能夠催化沿5′→3′方向合成 DNA。
    apply補(bǔ)平5'突出末端或切除3'突出末端; 基因點(diǎn)突變后的第二鏈合成; 采用該酶較強(qiáng)的3′→5′外切核酸酶的活性,通過置換合成法從DNA片段的3末端標(biāo)記探針。
    specs150U,750U,3,000U
Current page36, Total Pages42, Total Record166 First Prev 3435363738 Next Last Goto